News
Bioprocess International Tv Peter Moesta, Phd, Bristol-myers Squibb Co
wn.com
BioProcess International TV: Peter Moesta, Ph.D., Bristol-Myers Squibb Co., BioProcess International European Summit 2017, Working Together For Patients:...
U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing...
www.finanznachrichten.de
... biologics portfolio, and Devens is a key component of this strategy," said Peter Moesta, senior vice president, Biologics Manufacturing and ...
BMS Grows Biologics in $250M Expansion
www.genengnews.com
Devens, MA, complex will nearly double workforce, add R&D and clinical-trial scale capabilities.
Harbour BioMed Acquires Harbour Antibodies to Create Global,...
harbourantibodies.com
Previously, he served as Assistant Professor at Harvard Medical School; and; Peter Moesta, PhD, CEO of Adello Biologics, LLC. Dr. Moesta previously oversaw the production at Bristol-Myers Squibb of Opdivo® (nivolumab) and Yervoy® ( ipilimumab), two pioneering immuno oncology drugs, and played a ...
sortiert nach Relevanz / Datum